GeneDx Holdings (WGS) analyst forecast and price target
Analyst forecast
Consensus of 9 analyst ratings
Based on 4 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| BTIG | Maintained | Buy | $90.00 | Aug 4, 2026 |
| Canaccord Genuity | Maintained | Buy | $90.00 from $75.00 | Aug 4, 2026 |
| Guggenheim | Maintained | Buy | $74.00 from $70.00 | Jun 29, 2026 |
| Piper Sandler | Maintained | Overweight | $63.00 from $50.00 | Jun 23, 2026 |
| BTIG | Maintained | Buy | $90.00 from $170.00 | May 5, 2026 |
| Guggenheim | Maintained | Buy | $70.00 from $100.00 | May 5, 2026 |
| Wells Fargo | Maintained | Overweight | $75.00 from $155.00 | May 5, 2026 |
| Canaccord Genuity | Maintained | Buy | $75.00 from $100.00 | May 5, 2026 |
| Canaccord Genuity | Maintained | Buy | $100.00 from $170.00 | Apr 20, 2026 |
| Guggenheim | Maintained | Buy | $100.00 from $170.00 | Mar 30, 2026 |
| BTIG | Maintained | Buy | $170.00 from $200.00 | Feb 24, 2026 |
| Piper Sandler | Maintained | Overweight | $130.00 from $160.00 | Feb 24, 2026 |
| Wells Fargo | Upgraded | Equal-Weight → Overweight | $155.00 | Feb 9, 2026 |
| Canaccord Genuity | Maintained | Buy | $170.00 from $160.00 | Dec 22, 2025 |
| Wells Fargo | Maintained | Equal-Weight | $155.00 from $140.00 | Dec 15, 2025 |
| BTIG | Maintained | Buy | $200.00 from $165.00 | Dec 12, 2025 |
| Wells Fargo | Maintained | Equal-Weight | $140.00 from $95.00 | Nov 4, 2025 |
| BTIG | Maintained | Buy | $165.00 from $140.00 | Oct 29, 2025 |
| Guggenheim | Maintained | Buy | $170.00 from $115.00 | Oct 29, 2025 |
| Canaccord Genuity | Maintained | Buy | $160.00 from $155.00 | Oct 29, 2025 |
Frequently asked questions
What is the price target for WGS stock?
The average 12-month analyst price target for GeneDx Holdings (WGS) is $79.25, with a high estimate of $90.00 and a low of $63.00, across 4 analysts.
Is WGS a buy, sell, or hold?
Analysts covering GeneDx Holdings currently average a Buy rating: 9 buy, 0 hold and 0 sell, from 9 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for WGS?
The average price target of $79.25 implies 6.00% downside from the last price of $84.31.
What is the latest analyst rating on WGS?
On Aug 4, 2026, BTIG maintained GeneDx Holdings at Buy with a price target of $90.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.